Top 5 Takeaways Significant Underutilization of Antivirals: Review of 110 immunosuppressed Veterans Health Administration patients with nonsevere COVID-19 showed 80% were not offered antiviral drugs, primarily due to mild symptoms.
Author: Cody Micah Carmichael MPH, CPH
Top 5 Takeaways Variation in Cardiometabolic Disease Prevalence: The study found significant variation in the prevalence of diagnosed cardiometabolic diseases (diabetes, myocardial infarction, angina or coronary heart disease, and stroke)
Top 5 Takeaways Prevalence of Antihistamine-Related Overdoses: 14.7% of overdose deaths (13,574 cases) were antihistamine-positive, and 3.6% (3,345 cases) were antihistamine-involved during 2019-2020. Dominance of Diphenhydramine: The majority of these
Top 5 Takeaways Prevalence of Stigma and Discrimination: Hispanic or Latino persons with HIV reported high levels of stigma and health care discrimination, with women and American Indian or Alaska
Top 5 Takeaways High Prevalence of ACEs: During the COVID-19 pandemic, 73.1% of U.S. high school students reported at least one Adverse Childhood Experience (ACE), with 7.8% reporting four or
Top 5 Takeaways First Reported U.S. Case of Monkeypox from Needlestick in Healthcare: A nurse in Florida contracted monkeypox from a needlestick injury while collecting a swab from a patient’s
Top 5 Takeaways Effectiveness of Monovalent mRNA Vaccines: During the SARS-CoV-2 Omicron BA.1/BA.2 and BA.4/BA.5 periods, the effectiveness of three-dose monovalent mRNA vaccines against COVID-19–associated hospitalization waned over time. Vaccine
Top 5 Takeaways Vaccine Effectiveness (VE): Among immunocompromised adults, the VE of 2-dose monovalent mRNA COVID-19 vaccines against hospitalization during Omicron predominance was 36%. VE increased to 67% after a
Top 5 Takeaways This report details five cases of ocular monkeypox in the U.S. from July to September 2022, highlighting serious complications including vision impairment and prolonged illness. Patients with
Top 5 Takeaways Oral Antivirals for COVID-19: The study analyzes the dispensing of oral antiviral drugs, Paxlovid and Lagevrio, for COVID-19 treatment, focusing on zip code-level social vulnerability in the